USING BIOCHEMICAL SUBSTANCES IN COMPOSITION FOR PROPHYLAXIS AND TREATMENT OF MORBID STATE CAUSED BY CONTRACTION OF SMOOTH MUSCLE CELLS IN HUMAN ORGANS Russian patent published in 2006 - IPC A61K31/00 

Abstract RU 2280441 C2

FIELD: biochemistry, medicine.

SUBSTANCE: invention relates to the development of methods used in treatment and prophylaxis of morbid states caused by contraction of smooth muscle cells and based on using compositions comprising, for example, the following substances: ascorbic acid, 680 mg; ascorbyl palmitate, 620 mg; mixture of beta-, gamma- and delta-tocopherol, 22 mg; beta-carotene, 1665 mg; biotin, 65 mcg; calcium ascorbate, 1050 mg; calcium citrate, 200 mg; calcium glycynate, 35 mg; mixture of carotinoids (alpha-carotene, lutein, zeatin, cryptoxanthin), 50 mcg; cholecalciferol, 130 IU; chrome glycynate, 10 mcg; citrus bioflavonoids, 650 mg; coenzyme Q, 7 mg; copper glycynate, 330 mcg; cyanocobalamine, 20 mcg; d-alpha-tocopherol, 230 IU; calcium d-pantothenate , 40 mg; dicalcium phosphate, 15 mg; folic acid, 90 mcg; inositol, 35 mg; L-arginine, 790 mg; L-cysteine, 35 mg; L-lysine, 110 mg; L-proline, 110 mg; L-selenomethionine, 20 mcg; magnesium ascorbate. 1050 mg; magnesium citrate, 40 mg; magnesium glycynate, 40 mg; manganese chelate, 1300 mcg; molybdenum glycynate, 4 mcg; nicotinic acid, 10 mg; nicotinamide, 35 mg; potassium chelate, 20 mg; picnogenol, 7 mg; pyridoxine, 10 mg; riboflavin, 7 mg; thiamine, 7 mg, and zinc glycynate, 7 mg. Invention provides enhancing effectiveness in relief of morbid states associated with contraction of smooth muscles.

EFFECT: enhanced effectiveness and valuable medicinal properties of compositions.

4 cl, 2 tbl, 1 ex

Similar patents RU2280441C2

Title Year Author Number
METHODS AND COMPOSITION FOR DECREASING LIPOPROTEIN (a) CONTENT IN PLASMA AND REDUCING FACTORS FOR RISK OF CARDIOVASCULAR DISEASES 2001
  • Rat Mattias
RU2289406C2
POLYPHENOL-BASE PHARMACEUTICAL COMPOSITION POSSESSING NUTRIENT PROPERTIES AND ITS USING IN CANCER TREATMENT 2003
  • Rat Mattias
  • Netke Shrirang
  • Nedzvetski Aleksandra
RU2301666C2
SYNERGETIC COMPOSITION CONTAINING ASCORBATE AMD LYSINE FOR TREATMENT OF STATES ASSOCIATED WITH EXTRACELLULAR MATRIX DESTRUCTION 2001
  • Rat Mattias
RU2268038C2
COMPOSITION INHIBITING MATRIX METALLOPROTEINASES FOR TREATMENT OF NEOPLASM DISEASES 2002
  • Rat Mattias
  • Netke Shrirang
  • Ivanov Vadim
  • Rumi Vakhid M.
  • Nedzvetski Aleksandra
RU2284185C2
COMPOSITIONS OF BIOCHEMICAL COMPOUNDS INVOLVING IN CELL BIOENERGETIC METABOLISM AND METHOD FOR THEIR USING 2002
  • Rat Mattias
RU2301665C2
ESTROGEN AND OTHER HORMONE COMPOSITION CONTAINING ASCORBATE, LYSINE, PROLINE AND OTHER SUBSTANCES 2001
  • Rat Mattias
  • Nidzvitski Aleksandra
  • Netke Shrirang
  • Ivanov Vadim
RU2282449C2
DIETARY SUPPLEMENT (VERSIONS) 2007
  • Vekovtsev Andrej Alekseevich
  • Avstrievskikh Aleksandr Nikolaevich
  • Poznjakovskij Dmitrij Valer'Evich
RU2352147C2
POLYVITAMIN KIT FOR WOMEN 2010
  • Gromova Ol'Ga Alekseevna
RU2443422C2
OLIGOPEPTIDES OF METALLOPROTEINASE AND THERAPEUTIC USE THEREOF 2011
  • Rat Mattias
  • Nidzvetski Aleksandra
  • Rumi Vakhid M.
RU2585388C2
METALLOPROTEINASE OLIGOPEPTIDES AND THEIR THERAPEUTIC USE 2011
  • Rat Mattias
  • Nidzvetski Aleksandra
  • Rumi Vakhid M.
RU2680717C2

RU 2 280 441 C2

Authors

Rat Mattias

Dates

2006-07-27Published

2001-06-15Filed